Post COVID-19 Syndrome
A recent study conducted at the Sagol Hyperbaric Medicine and Research Center in Israel demonstrates that hyperbaric oxygen therapy (HBOT) can induce neuroplasticity and significantly improve cognitive, psychiatric, fatigue, sleep and pain symptoms in patients suffering from post-COVID-19 syndrome.
Studies show that increasing cerebral perfusion and activating neuroplasticity in brain regions with cognitive and/or emotional roles can improve post-COVID-19 symptoms. The benefits manifest themselves at the levels of cognitive, mental, endurance, sleep quality and pain.
Amir Hadanny, Shachar Finci, Merav Catalogna, Ramzia Abu Hamed, Calanit Korin, Levi Gabriella, Katia Adler-Vallach, Natalia Tarasula, Mahgna Hamad, Zemer Wang, Erez Lang, Yonatan Zemel, Yair Bechor, Noami Rahimi-Levene, Yonatan Shapira, Oleg Gorelik, Irma Tzur, Eduard Ilgiyaev, Avi Mizrachi, Eli Shiloah, Yasmin Maor, Osnat Lev-Zion Korach, Shai Efrati
Hyperbaric Oxygen Therapy for COVID-19 Patients: A Prospective, Randomized Controlled Trial9 Apr 2021
N.M. ALLAM, H.M. ELADL1, M.M. EID
Hyperbaric oxygen therapy as a supportive therapy for COVID-19 patients: a narrative review2022; 26: 5618-5623
Anders Kjellberg, Adrian Hassler, Emil Boström, Sara El Gharbi, Sarah Al-Ezerjawi, Jan Kowalski, Kenny A. Rodriguez-Wallberg, Judith Bruchfeld, Marcus Ståhlberg, Malin Nygren-Bonnier, Michael Runold & Peter Lindholm
Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trialBMC Infectious Diseases volume 23, Article number: 33 (2023)
Tim Robbins, Michael Gonevski, Cain Clark, Sudhanshu Baitule, Kavi Sharma, Angel Magar, Kiran Patel, Sailesh Sankar, Ioannis Kyrou, Asad,Ali Harpal S Randeva
Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising interventionClin Med (Lond). 2021 Nov; 21(6): e629–e632; DOI: 10.7861/clinmed.2021-0462; PMCID: PMC8806311; PMID: 34862223
Anders Kjellberg, Lina Abdel-Halim, Adrian Hassler, Sara El Gharbi, Sarah Al-Ezerjawi, Emil Boström, Carl Johan Sundberg, John Pernow, Koshiar Medson, Jan H Kowalski, Kenny A Rodriguez-Wallberg ,Xiaowei Zheng, Sergiu Catrina, Michael Runold, Marcus Ståhlberg, Judith Bruchfeld, Malin Nygren-Bonnier, Peter Lindholm
Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebocontrolled, double-blind, phase II clinical trialDOI:10.1136/bmjopen-2022-061870
Anders Kjellberg; Johan Douglas; Adrian Hassler; Sarah Al-Ezerjawi; Emil Boström; Lina Abdel-Halim; Lovisa Liwenborg; Eric Hetting; Anna-Dora Jonasdottir-Njåstad; Jan Kowalski; Sergiu-Bogdan Catrina; ; Kenny Rodriguez-Wallberg; Peter Lindholm
COVID-19 induced acute respiratory distress syndrome treated with Hyperbaric Oxygen: Interim safety report from a multicenter, randomised, open-label phase II clinical trial (COVID-19-HBO)DOI:10.21203/rs.3.rs-1494203/v1
Thiruppathy Palaniappan; Asif Shaikh; Navamani Kirthika
Effective Outcome of HBOT as an Adjuvant Therapy in Patients Diagnosed with COVID-19 in a Tertiary Care Hospital – A Preliminary StudyDOI:10.2478/jccm-2022-0008
Sead Žiga; Sead Žiga; Dejan Andrić; Sanja Jurić Banai; Kristina Franjić
The role of hyperbaric oxygenotherapy (HBOT) in the treatment of COVID-19 patientsDOI:10.26800/LV-143-11-12-9
Shahram Oliaei, SeyedAhmad SeyedAlinaghi, Mohammad Mehrtak, Amirali Karimi, Tayebeh Noori, Pegah Mirzapour, Alireza Shojaei, Mehrzad MohsseniPour, Seyed Peyman Mirghaderi, Sanam Alilou, Parnian Shobeiri, Hadiseh Azadi Cheshmekabodi, Esmaeil Mehraeen & Omid Dadras
The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic reviewEuropean Journal of Medical Research volume 26, Article number: 96 (2021)
Chih-Cheng Lai, Chi-Kuei Hsu, Muh-Yong Yen, Ping-Ing Lee, Wen-Chien Ko, Po-Ren Hsueh
Long COVID: An inevitable sequela of SARS-CoV-2 infectionhttps://doi.org/10.1016/j.jmii.2022.10.003
Diana Kitala, Wojciech Łabuś, Jerzy Kozielski, Przemysław Strzelec, Mariusz Nowak, Grzegorz Knefel, Piotr Dyjas, Krzysztof Materniak, Jolanta Kosmala, Jolanta Pająk, Jolanta Czop, Barbara Janda-Kalus, Barbara Marona, Anna Nowak-Wróżyna, Marcin Gierek, Jan Szczegielniak and Marek Kucharzewski
Preliminary Research on the Effect of Hyperbaric Oxygen Therapy in Patients with Post-COVID-19 SyndromeJ. Clin. Med. 2023, 12(1), 308; https://doi.org/10.3390/jcm12010308
Jacek Siewiera, Klaudia Brodaczewska, Natalia Jermakow, Arkadiusz Lubas, Krzysztof Kłos, Aleksandra Majewska, Jacek Kot
Effectiveness of Hyperbaric Oxygen Therapy in SARS-CoV-2 Pneumonia: The Primary Results of a Randomised Clinical TrialJ. Clin. Med. 2023, 12(1), 8; https://doi.org/10.3390/jcm12010008
Aisha M. Bhaiyat, Efrat Sasson, Zemer Wang, Sherif Khairy, Mouzayan Ginzarly, Umair Qureshi, Moin Fikree & Shai Efrati
Hyperbaric oxygen treatment for long coronavirus disease-19: a case reportJournal of Medical Case Reports volume 16, Article number: 80 (2022)
Shin Jie Yong, Shiliang Liu
Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapiesMedical Virology, 9 December 2021
Merav Catalogna, Efrat Sasson, Amir Hadanny, Yoav Parag, Shani Zilberman-Itskovich, Shai Efrati
Effects of hyperbaric oxygen therapy on functional and structural connectivity in post-COVID-19 condition patients: A randomized, sham-controlled trialNeuroImage: Clinical, Volume 36, 2022, 103218
Chia Siang Kow, Dinesh Sangarran Ramachandram & Syed Shahzad Hasan
Hyperbaric oxygen therapy to reverse post-COVID cognitive impairmentNeurol Sci 43, 6185–6186 (2022)
José Alfredo Gonzalez‑Ramirez Julio C. Ramírez‑Nava Sonia Gonzalez‑Lopez Bettina Sommer Héctor Solís‑Chagoyán Luis M. Montaño Bianca S. Romero‑Martínez Edgar Flores‑Soto
Hyperbaric oxygen therapy in overweight and obese patients with COVID‑19Published online on: October 12, 2021; https://doi.org/10.3892/wasj.2021.132
Shani Zilberman-Itskovich, Merav Catalogna, Efrat Sasson, Karin Elman-Shina, Amir Hadanny, Erez Lang, Shachar Finci, Nir Polak, Gregory Fishlev, Calanit Korin, Ran Shorer, Yoav Parag, Marina Sova & Shai Efrati
Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trialScientific Reports volume 12, Article number: 11252 (2022)
Guillermo A. Keller, Ivana Colaianni, Javier Coria, Guillermo Di Girolamo, Silvia Miranda
Clinical and biochemical short-term effects of hyperbaric oxygen therapy on SARS-Cov-2+ hospitalized patients with hypoxemic respiratory failurePublished:February 14, 2023 DOI:https://doi.org/10.1016/j.rmed.2023.107155
Marina Leitman, Shmuel Fuchs, Vladimir Tyomkin, Amir Hadanny, Shani Zilberman-Itskovich, Shai Efrati
The effect of hyperbaric oxygen therapy on myocardial function in post-COVID-19 syndrome patients: a randomized controlled trialScientific Reports volume 13, Article number: 9473 (2023), https://doi.org/10.1038/s41598-023-36570-x
Marina Leitman, Shmuel Fuchs, Vladimir Tyomkin, Amir Hadanny, Shani Zilberman-Itskovich, Shai Efrati
The effect of hyperbaric oxygen therapy on myocardial function in post-COVID-19 syndrome patients: a randomized controlled trialScientific Reports volume 13, Article number: 9473 (2023), https://doi.org/10.1038/s41598-023-36570-x
Alan A. Katz, Sandra Wainwright, Matthew P. Kelly, Pradeep Albert, Rosemary Byrne
Hyperbaric oxygen effectively addresses the pathophysiology of long COVID: clinical reviewFront. Med., 15 February 2024; Sec. Family Medicine and Primary Care; Volume 11 - 2024 | https://doi.org/10.3389/fmed.2024.1354088
Hyperbarium Articles
Keep up to date with the latest news in hyperbaric medicine. Accurate medical information in articles verified by experienced medical specialists.
